Abstract
Background: Chronic wound healing is a major challenge for the health care system around the globe. The current study was conducted to develop and characterize chemically cross-linked polyethylene glycol-co-poly (AMPS) hydrogel membranes to enhance the wound healing efficiency of antibiotic mupirocin (MP).
Methods: Free radical polymerization technique was used to develop hydrogel membranes. In an aqueous medium, polymer PEG-4000 was cross-linked with the monomer 2-acrylamido-2-methylpropane sulfonic acid (AMPS) in the presence of initiators ammonium peroxide sulfate (APS) and sodium hydrogen sulfite (SHS). N, N-Methylene-bis-acrylamide (MBA) was used as a cross-linker in preparing hydrogel membranes. Developed membranes were spherical, transparent, and had elasticity. FTIR, TGA/DSC, and SEM were used to characterize the polymeric system. Swelling behavior, drug loading, and release pattern at pH of 5.5 and 7.4, irritation study, ex vivo drug permeation, and deposition study were also evaluated.
Results: Formed membranes were spherical, transparent, and had elasticity. The formation of a stable polymeric network was confirmed by structural and thermal analysis. Evaluation of the drug permeability in the skin showed good permeation and retention capabilities. No irritancy to the skin was observed.
Conclusion: Based on the results obtained, the present study concluded that the formulated stable network might be an ideal network for the delivery of mupirocin in skin infections.
Keywords: Hydrogel membrane, Mupirocin, PEG-4000, AMPS, wound healing, in-vitro and ex-vivo analysis.
Graphical Abstract
[http://dx.doi.org/10.4103/japtr.JAPTR_147_19] [PMID: 32587820]
[http://dx.doi.org/10.1016/j.bioactmat.2020.02.004] [PMID: 32128464]
[http://dx.doi.org/10.1016/j.ijbiomac.2019.10.029] [PMID: 31622704]
[http://dx.doi.org/10.1016/j.ijbiomac.2020.03.248] [PMID: 32246960]
[http://dx.doi.org/10.1080/00914037.2018.1429437]
[http://dx.doi.org/10.1016/j.eurpolymj.2020.109853]
[http://dx.doi.org/10.1016/j.msec.2020.110743] [PMID: 32279739]
[http://dx.doi.org/10.1111/wrr.12175] [PMID: 24844328]
[http://dx.doi.org/10.1039/C9SC06192D] [PMID: 34122978]
[http://dx.doi.org/10.1016/j.jgar.2019.07.032] [PMID: 31442624]
[http://dx.doi.org/10.1021/acschembio.9b00969] [PMID: 31977176]
[http://dx.doi.org/10.1016/j.jconrel.2019.11.007] [PMID: 31715276]
[http://dx.doi.org/10.21037/ajo-18-97]
[http://dx.doi.org/10.1016/j.jsps.2019.04.010] [PMID: 31297030]
[http://dx.doi.org/10.1016/j.ejps.2013.10.006] [PMID: 24514452]
[http://dx.doi.org/10.1080/03639045.2017.1339077] [PMID: 28581830]
[http://dx.doi.org/10.1038/s41598-020-59510-5] [PMID: 32071320]
[http://dx.doi.org/10.1039/C6TB03222B] [PMID: 32263991]
[http://dx.doi.org/10.1016/j.carbpol.2020.116096] [PMID: 32172898]
[PMID: 33309972]
[http://dx.doi.org/10.1016/j.msec.2015.10.003] [PMID: 26652355]
[http://dx.doi.org/10.1016/j.ijbiomac.2020.06.087] [PMID: 32553980]
[http://dx.doi.org/10.1002/jbm.a.36886] [PMID: 31971330]
[http://dx.doi.org/10.1016/j.msec.2016.11.038] [PMID: 28024572]
[http://dx.doi.org/10.1002/term.193] [PMID: 19598204]
[http://dx.doi.org/10.1016/j.msec.2020.111696] [PMID: 33545855]
[http://dx.doi.org/10.1177/0885328221991948] [PMID: 33611960]
[http://dx.doi.org/10.2147/DDDT.S198413] [PMID: 31190737]
[http://dx.doi.org/10.1007/s00289-019-02755-6]
[http://dx.doi.org/10.1007/s40005-020-00472-1]
[http://dx.doi.org/10.1208/s12249-018-1131-z] [PMID: 30171450]
[http://dx.doi.org/10.1002/adv.22124]
[http://dx.doi.org/10.1016/j.carbpol.2020.116717] [PMID: 32829844]
[http://dx.doi.org/10.1208/s12249-021-02054-2] [PMID: 34129154]
[http://dx.doi.org/10.1016/j.jddst.2021.102952]
[http://dx.doi.org/10.1016/0168-3659(91)90117-V]
[http://dx.doi.org/10.1080/03639040600814676] [PMID: 16954103]
[http://dx.doi.org/10.1016/j.ijpharm.2008.06.028] [PMID: 18657601]
[PMID: 25272649]
[http://dx.doi.org/10.5731/pdajpst.2013.00898] [PMID: 23385560]
[http://dx.doi.org/10.1080/00914037.2012.664208]
[http://dx.doi.org/10.1002/app.12697]
[http://dx.doi.org/10.1007/s13726-018-0599-4]
[http://dx.doi.org/10.1016/j.molstruc.2014.07.049]
[http://dx.doi.org/10.3109/03639049709146154]
[http://dx.doi.org/10.1002/macp.200600331]
[http://dx.doi.org/10.1007/s00403-006-0713-x] [PMID: 17091276]
[http://dx.doi.org/10.1016/S0378-5173(97)00131-2]
[http://dx.doi.org/10.1023/A:1027313931273]
[http://dx.doi.org/10.1007/s00289-017-1967-5]
[http://dx.doi.org/10.1208/s12249-020-01694-0] [PMID: 32419084]
[http://dx.doi.org/10.1016/j.eurpolymj.2004.01.039]
[http://dx.doi.org/10.1016/j.jddst.2017.10.010]
[http://dx.doi.org/10.1080/1539445X.2017.1368559]
[http://dx.doi.org/10.1016/j.seppur.2007.04.005]
[http://dx.doi.org/10.1021/ma021079q]
[http://dx.doi.org/10.1002/ppap.201500194]
[http://dx.doi.org/10.1208/s12249-009-9220-7] [PMID: 19381834]
[http://dx.doi.org/10.1016/j.colsurfb.2013.04.045] [PMID: 23743255]
[http://dx.doi.org/10.1016/j.ijpharm.2014.09.033] [PMID: 25263100]